Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
17.00
-0.21 (-1.22%)
May 12, 2026, 3:00 PM CST

SHA:688488 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
503.95371.16335.34225.36134.91442.71
Trading Asset Securities
30.1180.19106.18215.75351.64163.31
Cash & Short-Term Investments
534.06451.35441.52441.1486.54606.02
Cash Growth
17.93%2.23%0.10%-9.34%-19.71%-22.41%
Accounts Receivable
199.57200.91162.92207.62134.7489.68
Other Receivables
7.190.010.030.01--
Receivables
206.77200.92162.96207.64134.7489.68
Inventory
257.92259.49254.97184.88156.15114.27
Other Current Assets
13.9526.9835.4838.7625.0216.97
Total Current Assets
1,013938.74894.93872.38802.46826.93
Property, Plant & Equipment
402.47404.26434.45443.54447.18327.3
Long-Term Investments
91.690.8269.6150.88148.8158.2
Goodwill
171.62171.62171.6213.2413.2413.24
Other Intangible Assets
149.71154.64175.47114.59117.62128.23
Long-Term Deferred Tax Assets
84.6583.7383.8554.2939.0219.32
Long-Term Deferred Charges
72.9965.8336.4183.969.1342.94
Other Long-Term Assets
73.152.973.2413.7418.0918.45
Total Assets
2,0591,9131,8701,7471,6561,435
Accounts Payable
85.9651.9757.6735.6727.3428.1
Accrued Expenses
15.8677.5761.9339.235.1120.11
Short-Term Debt
428.11365.18220.5255.55145.16-
Current Portion of Long-Term Debt
52.91116.41169.0580.070.07-
Current Portion of Leases
-2.164.223.782.054.23
Current Income Taxes Payable
8.440.820.82---
Current Unearned Revenue
6.65.2213.086.2533.122.43
Other Current Liabilities
77.7989.89121.7871.0488.8337.67
Total Current Liabilities
675.68709.21649.06491.57331.6892.54
Long-Term Debt
231.2471.7490.5169.9460-
Long-Term Leases
7.663.673.752.961.51.36
Long-Term Unearned Revenue
42.9643.7649.7450.2956.3725.05
Long-Term Deferred Tax Liabilities
11.72119.436.287.025.86
Total Liabilities
969.26839.37802.48621.03456.57124.82
Common Stock
420.78420.78420.78420.78420420
Additional Paid-In Capital
889.56887.33883.62888.35886.2873.78
Retained Earnings
-337.27-344.88-325.35-184.14-108.0716.12
Comprehensive Income & Other
1.441.451.840.550.85-0.1
Total Common Equity
974.51964.68980.891,1261,1991,310
Minority Interest
115.12108.5586.19---
Shareholders' Equity
1,0901,0731,0671,1261,1991,310
Total Liabilities & Equity
2,0591,9131,8701,7471,6561,435
Total Debt
719.92559.15488.03412.3208.775.59
Net Cash (Debt)
-185.85-107.8-46.528.8277.78600.43
Net Cash Growth
----89.63%-53.74%-23.12%
Net Cash Per Share
-0.44-0.26-0.110.070.671.40
Filing Date Shares Outstanding
380.31420.78420.78420.78420420
Total Common Shares Outstanding
380.31420.78420.78420.78420420
Working Capital
337.02229.53245.87380.81470.78734.39
Book Value Per Share
2.562.292.332.672.853.12
Tangible Book Value
653.18638.42633.81997.711,0681,168
Tangible Book Value Per Share
1.721.521.512.372.542.78
Buildings
-393.38393.46375.44344.92217.76
Machinery
-264.3260.49221.21198.6125.31
Construction In Progress
--2.183.1236.8295.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.